Accelerating the Future of Retinal Therapeutics

Join RetinAI at the Retinal Therapeutics Innovation Summit to see how we bridge the gap between complex data and clinical success for GA and iAMD. We empower both Sponsors & Clinical Sites with automated AI-driven precision and Advanced Analytics.

For Pharma & Researchers: Optimize Your R&D Pipeline

Accelerate development with research-validated structural biomarkers and automated AI workflows.

• Accelerate Candidate Identification: Find the right patients faster.
• Streamline Trials: Reduce trial size and operational overhead.
• Detect Effects Earlier: Identify treatment signals in GA and iAMD with unprecedented speed.

For Clinical Sites: Maximize Your Research Potential

Stop letting imaging protocols slow you down. Turn your site's data into a high-yield strategic asset.

• Eliminate Screen Failures: 44.5% of failures are due to imaging criteria. Our AI qualifies patients before the screening visit.
• Reduce Manual Burden: Replace high-cost manual reviews with automated, AI-powered workflows.
• Increase Yield: Ensure every patient entering your workflow meets the most complex imaging protocols.

Ready to transform your workflow? Book a meeting with the team today!

Meet the Team:

• Lisa Williams, Sr. Director Commercial Operations 
• Jonathan Sourris, Business Developer

‍

‍